TL;DR: UnitedHealthcare modified its Medicare Advantage medical policy for prostate services and impotence treatment, effective December 2, 2025. This update restructures coverage guidance across CPT codes 37243, 52441, 52442, 53855, 55899, and 64999 — redirecting billing teams to commercial policy criteria for several procedures that lack Medicare NCDs or LCDs.
UnitedHealthcare updated the prostate-services-procs-impotence-tx Medicare Advantage policy on December 2, 2025. The change affects prostate artery embolization (PAE), prostatic urethral lift (PUL), temporary prostatic stents, and nerve graft procedures. If your urology or interventional radiology billing team submits claims for any of these services under Medicare Advantage, your coverage reference points just changed.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | UnitedHealthcare |
| Policy | Prostate Services and Procedures and Impotence Treatment – Medicare Advantage Medical Policy |
| Policy Code | prostate-services-procs-impotence-tx |
| Change Type | Modified |
| Effective Date | December 2, 2025 |
| Impact Level | High |
| Specialties Affected | Urology, Interventional Radiology, General Surgery, DME billing |
| Key Action | Cross-reference UHC Commercial Medical Policy criteria for PAE, PUL, temporary stents, and nerve graft procedures before submitting claims under Medicare Advantage |
UnitedHealthcare Prostate Services Coverage Criteria and Medical Necessity Requirements 2025
The core structure of this UnitedHealthcare prostate services coverage policy is unusual — and worth understanding before you touch a claim.
For most procedures covered here, Medicare has no National Coverage Determination (NCD) and no Local Coverage Determination (LCD) or Local Coverage Article (LCA). That means there's no federal Medicare baseline to fall back on. Instead, UnitedHealthcare instructs billing teams to apply criteria from its own Commercial Medical Policy for guidance.
This matters for medical necessity determinations. When your team or your compliance officer asks "what does UHC require to establish medical necessity for this procedure under Medicare Advantage," the answer is: look at the commercial policy, not CMS guidance.
Prostate Artery Embolization (PAE) — The One Partial Exception
PAE for BPH-related lower urinary tract symptoms (LUTS) is the only procedure here with any Medicare framework. CMS has a general NCD for therapeutic embolization (NCD 20.28). But there is no LCD or LCA specific to PAE. UHC uses its own commercial criteria to supplement that general NCD.
The reasoning UHC provides is clinically grounded. Untreated BPH can cause chronic high-pressure retention, bladder outlet obstruction (BOO), acute urinary retention (AUR), and kidney injury. PAE billing under CPT 37243 needs to reflect documented failure of conservative management and appropriate clinical indicators for this procedure.
UHC explicitly states this criteria application is designed to reduce both inappropriate denials and inappropriate approvals. Read: they're building the record to defend prior authorization decisions in both directions.
The potential harms UHC acknowledges from incorrectly denying PAE are real. They include worsening bladder function, urinary tract infections, urethra narrowing, bladder and kidney stones, gross hematuria, and renal insufficiency. If your team gets a denial on CPT 37243, those clinical factors are your appeal ammunition.
Prostatic Urethral Lift (PUL) — No NCD, No LCD
Medicare has no NCD or LCD for PUL procedures — the UroLift® System is the most common example. CPT codes 52441 and 52442 cover cystourethroscopy with insertion of permanent adjustable transprostatic implants. HCPCS code L8699 (prosthetic implant, not otherwise specified) may also apply.
Coverage policy for PUL under UHC Medicare Advantage runs entirely through UHC's commercial policy for Prostate Surgeries and Interventions. Confirm your team is pulling criteria from that document, not from any Medicare reference.
Temporary Prostatic Stent — No Federal Coverage Determination
Insertion of a temporary prostatic urethral stent (CPT 53855) — including devices like the Spanner® and Memokath™ — has no NCD and no LCD. The same redirect applies: UHC commercial policy governs.
This is the pattern across this entire coverage policy. Medicare has not weighed in, and UHC has decided commercial standards fill that gap for Medicare Advantage enrollees.
Nerve Graft to Restore Erectile Function During Radical Prostatectomy
This procedure also has no NCD or LCD. Billing teams use unlisted codes here — CPT 55899 (unlisted procedure, male genital system) and CPT 64999 (unlisted procedure, nervous system). UHC routes coverage criteria to its commercial policy specifically titled "Nerve Graft to Restore Erectile Function During Radical Prostatectomy."
Unlisted codes always carry extra scrutiny. Expect to submit operative reports and clinical documentation with every claim. Prior authorization is likely required — verify this before the procedure date.
Impotence-Related Prosthetics and DME
The policy explicitly redirects impotence-related prosthetics and devices to UHC's Medicare Advantage policy for durable medical equipment (DME), prosthetics, orthotics, nutritional therapy, and medical supplies. If your team handles penile prosthetic billing, that's the governing document — not this one.
Coverage Indications at a Glance
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| Prostate artery embolization (PAE) for BPH-related LUTS | Covered when criteria met | CPT 37243 | NCD 20.28 (Therapeutic Embolization) applies; UHC commercial criteria supplement the NCD; no LCD/LCA |
| Prostatic urethral lift (PUL) — e.g., UroLift® | Covered when criteria met | CPT 52441, 52442, HCPCS L8699 | No NCD or LCD; UHC commercial criteria apply |
| Temporary prostatic stent — e.g., Spanner®, Memokath™ | Covered when criteria met | CPT 53855 | No NCD or LCD; UHC commercial criteria apply |
| Nerve graft to restore erectile function during radical prostatectomy | Covered when criteria met | CPT 55899, 64999 | No NCD or LCD; unlisted codes require documentation; UHC commercial criteria apply |
| Impotence-related prosthetics and devices | Refer to DME policy | See UHC DME/Prosthetics policy | Coverage governed by separate UHC Medicare Advantage DME policy |
UnitedHealthcare Prostate Services Billing Guidelines and Action Items 2025
This policy creates a specific operational problem: your team has to maintain two separate policy references for the same procedure depending on the plan type. Here's how to handle that before December 2, 2025 creates claim denials.
| # | Action Item |
|---|---|
| 1 | Pull the UHC Commercial Medical Policy documents now. You need three specific documents: "Prostate Surgeries and Interventions," "Nerve Graft to Restore Erectile Function During Radical Prostatectomy," and the UHC Medicare Advantage DME/Prosthetics policy. Your team should have these saved and accessible before any prostate service billing goes out under Medicare Advantage. |
| 2 | Update your charge capture and coverage verification workflows for CPT 37243. PAE billing runs under NCD 20.28, but the medical necessity criteria are UHC commercial. Your pre-authorization checklist needs to document BPH-related LUTS indicators, prior treatment history, and the absence of contraindications. Get this documentation before the service date. |
| 3 | Flag all prior authorization requirements before scheduling. Procedures billed with unlisted codes — CPT 55899 and 64999 for nerve graft — almost always require prior auth. Verify UHC's current prior authorization requirements for each procedure code. A missing auth on an unlisted code is a guaranteed claim denial. |
| 4 | Brief your urology and interventional radiology teams on the documentation standard. The clinical record needs to support medical necessity under UHC's commercial criteria, not generic Medicare standards. Operative reports, imaging, and prior treatment records should all be in the chart before you bill. For PAE in particular, document evidence of failed conservative management. |
| 5 | Audit recent claims for these codes against the December 2, 2025 effective date. If your team submitted claims for CPT 52441, 52442, 53855, 37243, 55899, or 64999 under UHC Medicare Advantage near or after the effective date and didn't apply commercial criteria, those claims are at risk. Run a targeted audit and rework any pending claims. |
| 6 | Check HCPCS L8699 billing for PUL procedures. L8699 is the unlisted prosthetic implant code that may accompany PUL procedures. Confirm this code is included in your charge capture when applicable, and that your team is applying UHC commercial criteria — not DME-specific criteria — for coverage. |
| 7 | Talk to your compliance officer if this dual-criteria structure is new to your team. Applying commercial medical policy criteria to Medicare Advantage claims is not unusual, but it requires your billing and clinical teams to be on the same page. If your organization hasn't documented this process formally, do it now. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Prostate Services Under prostate-services-procs-impotence-tx
CPT Codes — Covered When Selection Criteria Are Met
| Code | Type | Description | Procedure Group |
|---|---|---|---|
| 37243 | CPT | Vascular embolization or occlusion, inclusive of all radiological supervision and interpretation, intra-arterial (prostate artery embolization for BPH-related LUTS) | PAE for BPH-Related LUTS |
| 52441 | CPT | Cystourethroscopy, with insertion of permanent adjustable transprostatic implant; single implant | Prostatic Urethral Lift (PUL) |
| 52442 | CPT | Cystourethroscopy, with insertion of permanent adjustable transprostatic implant; each additional permanent adjustable transprostatic implant | Prostatic Urethral Lift (PUL) |
| 53855 | CPT | Insertion of a temporary prostatic urethral stent, including urethral measurement | Temporary Prostatic Stent |
| 55899 | CPT | Unlisted procedure, male genital system | Nerve Graft to Restore Erectile Function During Radical Prostatectomy |
| 64999 | CPT | Unlisted procedure, nervous system | Nerve Graft to Restore Erectile Function During Radical Prostatectomy |
HCPCS Codes — Covered When Selection Criteria Are Met
| Code | Type | Description | Procedure Group |
|---|---|---|---|
| L8699 | HCPCS | Prosthetic implant, not otherwise specified | Prostatic Urethral Lift (PUL) |
Key ICD-10-CM Diagnosis Codes
The policy does not list specific ICD-10-CM codes. Diagnosis coding should reflect the underlying indication — BPH-related LUTS, urinary retention, bladder outlet obstruction, or erectile dysfunction — consistent with documentation and UHC commercial criteria. Work with your coding team to confirm appropriate ICD-10 linkage for each procedure before submission.
Get the Full Picture for CPT 37243
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.